Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study.

Source:http://linkedlifedata.com/resource/pubmed/id/18163485

Download in:

View as

General Info

PMID
18163485